A bill aimed at discouraging spikes in drug prices is dead for the year. Senate Bill 1010 would have required drug companies to give notice any time they raised drug prices by more than 10% and to justify the increase. But the bill was gutted, and the latest version would have exempted up to 99% of drug hikes. So the bill's sponsor killed it.
State Senator Drops Drug Pricing Bill After Committee Revisions
Sponsored